Agios Pharmaceuticals, Inc. (AGIO) Discusses Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease - Slideshow (NASDAQ:AGIO) 2025-11-19
Agios PharmaceuticalsAgios Pharmaceuticals(US:AGIO) Seeking Alpha·2025-11-19 15:24

根据提供的文档内容，该文档不包含任何与公司或行业相关的实质性信息[1]